Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry
Author(s) -
J. L. Vogelzang,
Karlijn J. van Stralen,
Marlies Noordzij,
J. A. Diez,
Juan Jesús Carrero,
Cécile Couchoud,
Friedo W. Dekker,
Patrik Finne,
Denis Fouque,
James Heaf,
Andries J. Hoitsma,
T. Leivestad,
Johan De Meester,
Wendy Metcalfe,
Runólfur Pálsson,
Maurizio Postorino,
Pietro Ravani,
Raymond Vanholder,
Manfred Wallner,
C. Wanner,
Jaap W. Groothoff,
Kitty J. Jager
Publication year - 2015
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfv007
Subject(s) - medicine , renal replacement therapy , dialysis , population , mortality rate , kidney disease , malignancy , hemodialysis , proportional hazards model , cause of death , end stage renal disease , disease , environmental health
Infections and malignancies are the most common non-cardiovascular causes of death in patients on chronic renal replacement therapy (RRT). Here, we aimed to quantify the mortality risk attributed to infections and malignancies in dialysis patients and kidney transplant recipients when compared with the general population by age group and sex.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom